ABSTRACT
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
ABSTRACT
Recent surveys suggest that many parents are using illicit cannabis extracts in the hope of managing seizures in their children with epilepsy. In the current Australian study we conducted semi-structured interviews with families of children with diverse forms of epilepsy to explore their attitudes towards and experiences with using cannabis extracts. This included current or previous users of cannabis extracts to treat their child's seizures (n = 41 families), and families who had never used (n = 24 families). For those using cannabis, extracts were analysed for cannabinoid content, with specific comparison of samples rated by families as "effective" versus those rated "ineffective". Results showed that children given cannabis extracts tended to have more severe epilepsy historically and had trialled more anticonvulsants than those who had never received cannabis extracts. There was high variability in the cannabinoid content and profile of cannabis extracts rated as "effective", with no clear differences between extracts perceived as "effective" and "ineffective". Contrary to family's expectations, most samples contained low concentrations of cannabidiol, while Δ9-tetrahydrocannabinol was present in nearly every sample. These findings highlight profound variation in the illicit cannabis extracts being currently used in Australia and warrant further investigations into the therapeutic value of cannabinoids in epilepsy.
Subject(s)
Cannabis/chemistry , Epilepsy/drug therapy , Plant Extracts/therapeutic use , Adolescent , Australia , Cannabinoids/analysis , Cannabinoids/urine , Child , Child, Preschool , Dose-Response Relationship, Drug , Drug Administration Routes , Female , Humans , Infant , Male , Plant Extracts/administration & dosage , Plant Extracts/pharmacology , Plant Extracts/urine , Terpenes/analysisABSTRACT
INTRODUCTION: Cannabis intoxication adversely affects health, yet persistent effects following short-term abstinence in long-term cannabis users are unclear. This matched-subjects, cross-sectional study compared health outcomes of long-term cannabis and long-term tobacco-only users, relative to population norms. METHODS: Nineteen long-term (mean 32.3years of use, mean age 55.7years), abstinent (mean 15h) cannabis users and 16 long-term tobacco users (mean 37.1years of use, mean age 52.9years), matched for age, educational attainment, and lifetime tobacco consumption, were compared on measures of learning and memory, response inhibition, information-processing, sustained attention, executive control, and mental and physical health. RESULTS: Cannabis users exhibited poorer overall learning and delayed recall and greater interference and forgetting than tobacco users, and exhibited poorer recall than norms. Inhibition and executive control were similar between groups, but cannabis users had slower reaction times during information processing and sustained attention tasks. Cannabis users had superior health satisfaction and psychological, somatic, and general health than tobacco users and had similar mental and physical health to norms whilst tobacco users had greater stress, role limitations from emotional problems, and poorer health satisfaction. CONCLUSIONS: Long-term cannabis users may exhibit deficits in some cognitive domains despite short-term abstinence and may therefore benefit from interventions to improve cognitive performance. Tobacco alone may contribute to adverse mental and physical health outcomes, which requires appropriate control in future studies.
Subject(s)
Health Status , Marijuana Use/psychology , Mental Health , Mental Processes , Tobacco Smoking/psychology , Attention , Cognition , Cross-Sectional Studies , Executive Function , Female , Humans , Inhibition, Psychological , Learning , Male , Memory , Middle Aged , Reaction Time , Tobacco Smoking/physiopathologyABSTRACT
Cannabis is a common recreational drug that is generally considered to have low addictive potential. However, an increasing number of cannabis users are seeking treatment for dependence on the drug. There is interest in using agonist (substitution) pharmacotherapies to treat cannabis dependence and here we outline a novel approach involving a buccal spray (nabiximols) that contains tetrahydrocannabinol (THC) and cannabidiol (CBD). We review recent research with nabiximols and highlight findings relevant to clinical practice.
Subject(s)
Cannabidiol/therapeutic use , Dronabinol/therapeutic use , Marijuana Abuse/drug therapy , Substance Withdrawal Syndrome/drug therapy , Drug Combinations , HumansABSTRACT
Under certain environmental situations, selection may favour the ability of females to adjust the sex ratio of their offspring. Two recent studies have suggested that viviparous scincid lizards can modify the sex ratio of the offspring they produce in response to the operational sex ratio (OSR). Both of the species in question belong to genera that have also recently been shown to exhibit temperature-dependent sex determination (TSD). Here we test whether pregnant montane water skinks (Eulamprus tympanum) utilise TSD to select offspring sex in response to population wide imbalances in the OSR, by means of active thermoregulation. We use a combination of laboratory and field-based experiments, and conduct the first field-based test of this hypothesis by maintaining females in outdoor enclosures of varying OSR treatments throughout pregnancy. Although maternal body temperature during pregnancy was influenced by OSR, the variation in temperature was not great enough to affect litter sex ratios or any other phenotypic traits of the offspring.
Subject(s)
Lizards/physiology , Sex Determination Analysis , Sex Ratio , Animals , Female , Male , Temperature , Viviparity, NonmammalianABSTRACT
A general problem in evolutionary biology is that quantitative tests of theory usually require a detailed knowledge of the underlying trade-offs, which can be very hard to measure. Consequently, tests of theory are often constrained to be qualitative and not quantitative. A solution to this problem can arise when life histories are viewed in a dimensionless way. Recently, dimensionless theory has been developed to predict the size and age at which individuals should change sex. This theory predicts that the size at sex change/maximum size (L50/L(max)), and the age at sex change/age at first breeding (tau/alpha) should both be invariant. We found support for these two predictions across 52 species of fish. Fish change sex when they are 80% of their maximum body size, and 2.5 times their age at maturity. This invariant result holds despite a 60 and 25 fold difference across species in maximum size and age at sex change. These results suggest that, despite ignoring many biological complexities, relatively simple evolutionary theory is able to explain quantitatively at what point sex change occurs across fish species. Furthermore, our results suggest some very broad generalities in how male fitness varies with size and age across fish species with different mating systems.
